Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Gewirtz

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Ciba Foundation Symposium|January 1, 1997
Oligonucleotide therapeutics for human leukaemiaA M Gewirtz
Stem Cells (Dayton, Ohio)|January 1, 1996
Methodologic approaches for investigating human megakaryocyte development at a molecular levelA M Gewirtz
Progress in Clinical and Biological Research|January 1, 1990
In vitro regulation of human megakaryocyte maturationA M Gewirtz
Advances in Experimental Medicine and Biology|January 1, 1988
Exogenous and endogenous regulations of human megakaryocytopoiesisA M Gewirtz
Annals of the New York Academy of Sciences|October 28, 1992
Therapeutic applications of antisense DNA in the treatment of human leukemiaA M Gewirtz
Critical Reviews in Oncogenesis|January 1, 1997
Antisense oligonucleotide therapeutics for human leukemiaA M Gewirtz
Seminars in Hematology|January 1, 1986
Human megakaryocytopoiesisA M Gewirtz
Oncogene|June 23, 1999
Myb targeted therapeutics for the treatment of human malignanciesA M Gewirtz
Thrombosis and Haemostasis|July 1, 1995
Megakaryocytopoiesis: the state of the artA M Gewirtz
Current Opinion in Molecular Therapeutics|November 21, 2001
Oligonucleotide therapeutics: clothing the emperorA M Gewirtz
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Ciba Foundation Symposium|January 1, 1997
Oligonucleotide therapeutics for human leukaemiaA M Gewirtz
Stem Cells (Dayton, Ohio)|January 1, 1996
Methodologic approaches for investigating human megakaryocyte development at a molecular levelA M Gewirtz
Progress in Clinical and Biological Research|January 1, 1990
In vitro regulation of human megakaryocyte maturationA M Gewirtz
Advances in Experimental Medicine and Biology|January 1, 1988
Exogenous and endogenous regulations of human megakaryocytopoiesisA M Gewirtz
Annals of the New York Academy of Sciences|October 28, 1992
Therapeutic applications of antisense DNA in the treatment of human leukemiaA M Gewirtz
Critical Reviews in Oncogenesis|January 1, 1997
Antisense oligonucleotide therapeutics for human leukemiaA M Gewirtz
Seminars in Hematology|January 1, 1986
Human megakaryocytopoiesisA M Gewirtz
Oncogene|June 23, 1999
Myb targeted therapeutics for the treatment of human malignanciesA M Gewirtz
Thrombosis and Haemostasis|July 1, 1995
Megakaryocytopoiesis: the state of the artA M Gewirtz
Current Opinion in Molecular Therapeutics|November 21, 2001
Oligonucleotide therapeutics: clothing the emperorA M Gewirtz
Pageof 13